NO20030856D0 - Membranpenetrerende peptider og anvendelse av disse - Google Patents
Membranpenetrerende peptider og anvendelse av disseInfo
- Publication number
- NO20030856D0 NO20030856D0 NO20030856A NO20030856A NO20030856D0 NO 20030856 D0 NO20030856 D0 NO 20030856D0 NO 20030856 A NO20030856 A NO 20030856A NO 20030856 A NO20030856 A NO 20030856A NO 20030856 D0 NO20030856 D0 NO 20030856D0
- Authority
- NO
- Norway
- Prior art keywords
- penetrating peptides
- membrane penetrating
- interest
- vivo
- cells
- Prior art date
Links
- 239000012528 membrane Substances 0.000 title abstract 4
- 230000000149 penetrating effect Effects 0.000 title abstract 4
- 102000004196 processed proteins & peptides Human genes 0.000 title abstract 4
- 108090000765 processed proteins & peptides Proteins 0.000 title abstract 4
- 150000001875 compounds Chemical class 0.000 abstract 2
- 239000000969 carrier Substances 0.000 abstract 1
- 238000000338 in vitro Methods 0.000 abstract 1
- 238000001727 in vivo Methods 0.000 abstract 1
- 230000003834 intracellular effect Effects 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 102000004169 proteins and genes Human genes 0.000 abstract 1
- 108090000623 proteins and genes Proteins 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
- C12N15/62—DNA sequences coding for fusion proteins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
- C07K14/4702—Regulators; Modulating activity
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
- C07K2319/03—Fusion polypeptide containing a localisation/targetting motif containing a transmembrane segment
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
- C07K2319/09—Fusion polypeptide containing a localisation/targetting motif containing a nuclear localisation signal
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
- C07K2319/10—Fusion polypeptide containing a localisation/targetting motif containing a tag for extracellular membrane crossing, e.g. TAT or VP22
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/40—Fusion polypeptide containing a tag for immunodetection, or an epitope for immunisation
- C07K2319/43—Fusion polypeptide containing a tag for immunodetection, or an epitope for immunisation containing a FLAG-tag
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/50—Fusion polypeptide containing protease site
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/60—Fusion polypeptide containing spectroscopic/fluorescent detection, e.g. green fluorescent protein [GFP]
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Genetics & Genomics (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- General Health & Medical Sciences (AREA)
- Zoology (AREA)
- Molecular Biology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biophysics (AREA)
- Biotechnology (AREA)
- Biochemistry (AREA)
- Medicinal Chemistry (AREA)
- Wood Science & Technology (AREA)
- General Engineering & Computer Science (AREA)
- Plant Pathology (AREA)
- Public Health (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Microbiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Veterinary Medicine (AREA)
- Physics & Mathematics (AREA)
- Toxicology (AREA)
- Gastroenterology & Hepatology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
- Immobilizing And Processing Of Enzymes And Microorganisms (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US22764700P | 2000-08-25 | 2000-08-25 | |
| GBGB0103110.3A GB0103110D0 (en) | 2000-08-25 | 2001-02-07 | A membrane penetrating peptide encoded by a nuclear localization sequence from human period 1 |
| PCT/US2001/026421 WO2002018572A2 (en) | 2000-08-25 | 2001-08-23 | Membrane penetrating peptides and uses thereof |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| NO20030856D0 true NO20030856D0 (no) | 2003-02-24 |
| NO20030856L NO20030856L (no) | 2003-04-24 |
| NO332050B1 NO332050B1 (no) | 2012-06-11 |
Family
ID=26245698
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO20030856A NO332050B1 (no) | 2000-08-25 | 2003-02-24 | Fusjonsprotein for avlevering av et organisk molekyl inn i en celle |
Country Status (9)
| Country | Link |
|---|---|
| EP (1) | EP1360311B1 (no) |
| AT (1) | ATE391791T1 (no) |
| AU (1) | AU8524901A (no) |
| CA (1) | CA2420350C (no) |
| IL (1) | IL154589A0 (no) |
| MX (1) | MXPA03001622A (no) |
| NO (1) | NO332050B1 (no) |
| NZ (1) | NZ524386A (no) |
| WO (1) | WO2002018572A2 (no) |
Families Citing this family (28)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20030086927A1 (en) | 1995-11-01 | 2003-05-08 | University Of Southern California | Expression of cyclin G1 in tumors |
| DE69839243T2 (de) | 1997-04-10 | 2009-04-30 | University Of Southern California, Los Angeles | Sich an extrazelluläre matrixbestandteile anbindende modifizierte proteine |
| FR2781674B1 (fr) * | 1998-07-31 | 2002-06-28 | Inst Nat Sante Rech Med | Utilisation de nouveaux agents inducteurs de mort cellulaire en synergie avec les interferons |
| AU2736400A (en) | 1999-01-27 | 2000-08-18 | University Of South Florida | Inhibition of stat3 signal transduction for human cancer therapy |
| WO2003062398A2 (en) * | 2002-01-23 | 2003-07-31 | The Government Of The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services | NEW TUMOR SUPPRESSOR GENE, p28ING5 |
| US20040002455A1 (en) * | 2002-01-29 | 2004-01-01 | Aventis Pasteur, Ltd. | Targeted immunogens |
| KR20030078115A (ko) * | 2002-03-28 | 2003-10-08 | (주)코아바이오텍 | 펩타이드 유전자 전달매체 및 이를 이용한 유전자 전달 방법 |
| EP1495045B1 (en) * | 2002-03-29 | 2009-09-02 | Creagene, Inc. | Cytoplasmic transduction peptides and uses thereof |
| SE0201863D0 (en) * | 2002-06-18 | 2002-06-18 | Cepep Ab | Cell penetrating peptides |
| US7638122B2 (en) | 2003-03-07 | 2009-12-29 | University Of South Florida | Stat3 antagonists and their use as vaccines against cancer |
| US20070178066A1 (en) | 2003-04-21 | 2007-08-02 | Hall Frederick L | Pathotropic targeted gene delivery system for cancer and other disorders |
| AU2004312548A1 (en) * | 2003-12-31 | 2005-07-21 | Sanofi Pasteur, Inc. | Targeted immunogens |
| EP1950294B1 (en) * | 2005-10-28 | 2012-01-18 | Mitsubishi Tanabe Pharma Corporation | Novel cell penetrating peptide |
| CN101374860A (zh) | 2005-12-23 | 2009-02-25 | 技术转让合伙人公司 | 用作神经递质分泌抑制剂和肌肉松弛诱导物的合成肽 |
| US7981446B2 (en) * | 2007-11-26 | 2011-07-19 | Forhumantech. Co., Ltd. | Pharmaceutical compositions and methods for delivering nucleic acids into cells |
| EP2250278B1 (en) | 2008-02-21 | 2023-04-05 | Burnham Institute for Medical Research | Methods and compositions related to peptides and proteins with c-terminal elements |
| WO2010117079A1 (ja) | 2009-04-10 | 2010-10-14 | 東亞合成株式会社 | 神経分化誘導ペプチド及びその利用 |
| BRPI1015424B1 (pt) | 2009-06-22 | 2022-01-18 | Burnham Institute For Medical Research | Composição compreendendo um elemento cendr e uma co-composição e composição para uso no reforço da internalização, penetração, ou ambas, de uma co-composição |
| US8603967B2 (en) | 2009-07-29 | 2013-12-10 | Toagosei Co., Ltd. | Carrier peptide fragment and use thereof |
| JP5858284B2 (ja) * | 2009-07-29 | 2016-02-10 | 東亞合成株式会社 | キャリアペプチドフラグメントとその利用 |
| WO2011013698A1 (ja) * | 2009-07-29 | 2011-02-03 | 東亞合成株式会社 | キャリアペプチドフラグメント及びその利用 |
| EP2730589B1 (en) | 2009-11-02 | 2015-12-30 | Toagosei Co., Ltd. | Peptide capable of promoting cell proliferation and use thereof |
| JP5854283B2 (ja) | 2010-06-04 | 2016-02-09 | 東亞合成株式会社 | 細胞増殖促進ペプチド及びその利用 |
| US9238796B2 (en) | 2010-06-04 | 2016-01-19 | Toagosei Co. Ltd. | Cell growth-promoting peptide and use thereof |
| US9370182B2 (en) | 2012-05-28 | 2016-06-21 | Toagosei Co., Ltd. | Antimicrobial peptide and use thereof |
| WO2014061749A1 (ja) | 2012-10-18 | 2014-04-24 | 東亞合成株式会社 | ２型ｔｎｆ受容体の発現を抑制する合成ペプチド及びその利用 |
| KR101671114B1 (ko) | 2015-06-26 | 2016-10-31 | 충북대학교 산학협력단 | Ｕｌｋ２로부터 유래된 핵 위치화 신호 펩타이드 및 이의 용도 |
| MX2024001708A (es) * | 2021-08-06 | 2024-04-23 | Univ Pennsylvania | Composiciones y métodos para tratamiento y prevención de proteínas mal plegadas. |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5962415A (en) * | 1996-09-20 | 1999-10-05 | Bristol-Myers Squibb Co. | Compositions comprising a peptide inhibitor of nuclear protein translocation and an immunosuppressant and methods of use thereof |
| WO1998049325A1 (en) * | 1997-04-28 | 1998-11-05 | Mcgill University | Reporter fusion proteins, expression vectors and transfected cell lines thereof for the analysis of nuclear transport |
| SE9801055D0 (sv) * | 1998-03-25 | 1998-03-25 | Inst Of Molecul & Cell Biology | Use of growth hormone binding protein (GHBP) |
| EP1235914A2 (en) * | 1999-11-24 | 2002-09-04 | Joseph Rosenecker | Polypeptides comprising multimers of nuclear localization signals or of protein transduction domains and their use for transferring molecules into cells |
| CN1981873A (zh) * | 2000-06-09 | 2007-06-20 | 莱古伦公司 | 制备微胶粒的方法和所述微胶粒的用途 |
-
2001
- 2001-08-23 NZ NZ524386A patent/NZ524386A/en not_active IP Right Cessation
- 2001-08-23 AU AU8524901A patent/AU8524901A/xx active Pending
- 2001-08-23 CA CA2420350A patent/CA2420350C/en not_active Expired - Lifetime
- 2001-08-23 IL IL15458901A patent/IL154589A0/xx unknown
- 2001-08-23 MX MXPA03001622A patent/MXPA03001622A/es active IP Right Grant
- 2001-08-23 AT AT01964392T patent/ATE391791T1/de not_active IP Right Cessation
- 2001-08-23 EP EP01964392A patent/EP1360311B1/en not_active Expired - Lifetime
- 2001-08-23 WO PCT/US2001/026421 patent/WO2002018572A2/en not_active Ceased
-
2003
- 2003-02-24 NO NO20030856A patent/NO332050B1/no not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| NZ524386A (en) | 2005-10-28 |
| NO20030856L (no) | 2003-04-24 |
| IL154589A0 (en) | 2003-09-17 |
| CA2420350C (en) | 2010-07-13 |
| EP1360311A2 (en) | 2003-11-12 |
| ATE391791T1 (de) | 2008-04-15 |
| EP1360311B1 (en) | 2008-04-09 |
| CA2420350A1 (en) | 2002-03-07 |
| AU8524901A (en) | 2002-03-13 |
| NO332050B1 (no) | 2012-06-11 |
| WO2002018572A2 (en) | 2002-03-07 |
| WO2002018572A3 (en) | 2003-09-12 |
| MXPA03001622A (es) | 2004-09-06 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO20030856D0 (no) | Membranpenetrerende peptider og anvendelse av disse | |
| BR0113477A (pt) | Peptìdios de penetração em membranas e usos dos mesmos | |
| IL172854A0 (en) | Autologous self-tolerance inducing cells of monocytic origin and their use in pharmaceutical preparations | |
| DE69734605D1 (de) | Abgeschwächter salmonellenstamm, gebraucht als vehikel zur oralen immunisierung | |
| YU9404A (sh) | Multimerna, usmerena kontrastna sredstva na bazi peptida | |
| DE60144145D1 (de) | Subtilisin-variante | |
| BR0207775A (pt) | Lipossomos anfotéricos métodos para carregamento dos mesmos com ingredientes ativos e sua utilização | |
| CR7786A (es) | Anticuerpos neutralizantes contra gdf-8 y el uso de los mismos | |
| IN2004CH02386A (no) | ||
| DE69942459D1 (de) | Isolierte nukleinsäuremoleküle die t-zellen induzierbare faktoren kodieren (tif), kodierte proteine und ihre anwendung | |
| DK1401869T3 (da) | Molekyler og fremgangsmåder til inhibering af udskillkelse af kim 1 | |
| NO20032286D0 (no) | Anvendelse av CLyA-hemolysin for utskillelse av proteiner | |
| NO20031860D0 (no) | Kahalaolid F | |
| DK1178726T3 (da) | Vandig opløsning til konservering af væv og organer | |
| YU90301A (sh) | Konjugati i postupci za njihovu proizvodnju i njihova upotreba za transport molekula kroz biološke membrane | |
| DK1234025T3 (da) | Humane enzymer fra metalloproteasefamilien | |
| AU2002326070A1 (en) | Peyers's patch and/or m-celle targeting ligands | |
| DE60327710D1 (de) | Modifizierte zytokine für krebs therapie | |
| SE0103765D0 (sv) | New use | |
| BR0316544A (pt) | Compostos calcilìticos | |
| DK1230261T3 (da) | NY-ESO-1 Nonapeptidderivater og anvendelser af disse | |
| GB2379446A (en) | Cells,culture methods and their uses | |
| DE50308032D1 (de) | Isoliertes fluoreszierendes protein aus clytia gregaria cgfp, sowie dessen verwendung | |
| NO20060781L (no) | Anvendelse av loselig CD164 ved inflammatoriske og/eller autoimmune lidelser | |
| ATE466077T1 (de) | Eine metacaspasen-klasse |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| CHAD | Change of the owner's name or address (par. 44 patent law, par. patentforskriften) |
Owner name: AVENTISUB LLC, US |
|
| MK1K | Patent expired |